235 related articles for article (PubMed ID: 36629684)
21. Intra-parotid facial nerve multiple plexiform neurofibroma in patient with NF1.
Fadda MT; Verdino G; Mustazza MC; Bartoli D; Iannetti G
Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):553-7. PubMed ID: 18329107
[TBL] [Abstract][Full Text] [Related]
22. [Plexiform neurofibroma of the bladder associated with neurofibromatosis type 1: a case report].
Nakazawa S; Yoneda S; Takezawa K; Tanigawa G; Fujita K; Okumi M; Hosomi M; Fukuhara S; Fushimi H; Yamaguchi S
Hinyokika Kiyo; 2012 Apr; 58(4):215-8. PubMed ID: 22684263
[TBL] [Abstract][Full Text] [Related]
23. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
[TBL] [Abstract][Full Text] [Related]
24. Plexiform Neurofibroma With Activating KRAS Mutation and Segmental Presentation Involving the Unilateral Eyelid.
Stallworth JY; Smith LD; Vagefi MR; Pekmezci M
Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):e104-e106. PubMed ID: 35797671
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis.
Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D
Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083
[TBL] [Abstract][Full Text] [Related]
26. Solitary plexiform neurofibroma of the tongue: report of a case with no evidence of neurofibromatosis type 1.
Zhang Y; Chen MWJ; Petersson F; Lim AAT
Int J Oral Maxillofac Surg; 2023 Dec; 52(12):1246-1249. PubMed ID: 37080888
[TBL] [Abstract][Full Text] [Related]
27. Management of neurofibromatosis type 1-associated plexiform neurofibromas.
Fisher MJ; Blakeley JO; Weiss BD; Dombi E; Ahlawat S; Akshintala S; Belzberg AJ; Bornhorst M; Bredella MA; Cai W; Ferner RE; Gross AM; Harris GJ; Listernick R; Ly I; Martin S; Mautner VF; Salamon JM; Salerno KE; Spinner RJ; Staedtke V; Ullrich NJ; Upadhyaya M; Wolters PL; Yohay K; Widemann BC
Neuro Oncol; 2022 Nov; 24(11):1827-1844. PubMed ID: 35657359
[TBL] [Abstract][Full Text] [Related]
28. Is a plexiform neurofibroma pathognomonic of neurofibromatosis type I?
Lin V; Daniel S; Forte V
Laryngoscope; 2004 Aug; 114(8):1410-4. PubMed ID: 15280718
[TBL] [Abstract][Full Text] [Related]
29. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
[TBL] [Abstract][Full Text] [Related]
30. Oral soft tissue alterations in patients with neurofibromatosis.
Jouhilahti EM; Visnapuu V; Soukka T; Aho H; Peltonen S; Happonen RP; Peltonen J
Clin Oral Investig; 2012 Apr; 16(2):551-8. PubMed ID: 21301902
[TBL] [Abstract][Full Text] [Related]
31. NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.
Yu Y; Choi K; Wu J; Andreassen PR; Dexheimer PJ; Keddache M; Brems H; Spinner RJ; Cancelas JA; Martin LJ; Wallace MR; Legius E; Vogel KS; Ratner N
Acta Neuropathol; 2020 Jan; 139(1):157-174. PubMed ID: 31664505
[TBL] [Abstract][Full Text] [Related]
32. Concomitant variants in NF1, LZTR1 and GNAZ genes probably contribute to the aggressiveness of plexiform neurofibroma and warrant treatment with MEK inhibitor.
Cohen-Barak E; Toledano-Alhadef H; Danial-Farran N; Livneh I; Mwassi B; Hriesh M; Zagairy F; Gafni-Amsalem C; Bashir H; Khayat M; Warrour N; Sher O; Marom D; Postovsky S; Dujovny T; Ziv M; Shalev SA
Exp Dermatol; 2022 May; 31(5):775-780. PubMed ID: 34913528
[TBL] [Abstract][Full Text] [Related]
33. Plexiform neurofibromas express the transcription factor Gli1.
Endo H; Oikawa A; Utani A; Shinkai H
Dermatology; 2004; 209(4):284-7. PubMed ID: 15539889
[TBL] [Abstract][Full Text] [Related]
34. Giant plexiform neurofibroma in a patient with neurofibromatosis type I.
Rallis E; Ragiadakou D
Dermatol Online J; 2009 May; 15(5):7. PubMed ID: 19624985
[TBL] [Abstract][Full Text] [Related]
35. NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas.
Kluwe L; Friedrich RE; Korf B; Fahsold R; Mautner VF
Hum Mutat; 2002 Mar; 19(3):309. PubMed ID: 11857752
[TBL] [Abstract][Full Text] [Related]
36. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
[TBL] [Abstract][Full Text] [Related]
37. [Progress in diagnosis and treatment of neurofibromatosis in children].
Wang S; Li Y; Zhang J; Ni X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jun; 36(6):477-482. PubMed ID: 35822370
[No Abstract] [Full Text] [Related]
38. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
[TBL] [Abstract][Full Text] [Related]
39. High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1.
Trovó-Marqui AB; Goloni-Bertollo EM; Valério NI; Pavarino-Bertelli EC; Muniz MP; Teixeira MF; Antonio JR; Tajara EH
Braz J Med Biol Res; 2005 Sep; 38(9):1441-7. PubMed ID: 16138229
[TBL] [Abstract][Full Text] [Related]
40. Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.
Robertson KA; Nalepa G; Yang FC; Bowers DC; Ho CY; Hutchins GD; Croop JM; Vik TA; Denne SC; Parada LF; Hingtgen CM; Walsh LE; Yu M; Pradhan KR; Edwards-Brown MK; Cohen MD; Fletcher JW; Travers JB; Staser KW; Lee MW; Sherman MR; Davis CJ; Miller LC; Ingram DA; Clapp DW
Lancet Oncol; 2012 Dec; 13(12):1218-24. PubMed ID: 23099009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]